PPBT - Purple Biotech Ltd. Quarterly EPS earnings growth
Purple Biotech is developing a system to combat tumor drug resistance via its patented CM24 antibody. The percentage change in quarterly EPS reflects the market's interpretation of these achievements, where the 109.60 level captures fresh values. However, the risk of share dilution due to R&D costs persists, even though the company's molecules effectively suppress metastatic cancer defenses.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_PPBT_-_Purple-Biotech_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Kitov Pharma (PPBT): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/12/2026 | 👁️GURU.Markets👁️")
Kitov Pharma (PPBT) - metric breakdowns and financial figures
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Debt to Equity Purple Biotech|PPBT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Purple Biotech|PPBT - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio Purple Biotech Corp|PPBT - Company Long-Term Debt|Company Short-Term Debts Purple Biotech|Quick Liquidity Indicator purple-biotech.com
- earnings and market multiples details:
PPBT - Final Profit|Projected Future Earnings Purple Biotech|PPBT - Price to Earnings Ratio|Forward P/E Multiple Purple Biotech Corp|PPBT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Purple Biotech Corp|PPBT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Purple Biotech|PPBT - Earnings per share for the last four quarters|Quarterly EPS earnings growth purple-biotech.com|PPBT - Earnings per share growth rate in current year|Earnings growth forecast for next year Purple Biotech
General company analysis:Purple Biotech
This metric measures the quarterly growth rate of earnings per share, reflecting the actual efficiency of business scaling without market distortions. For Purple Biotech (PPBT), which minimizes capital expenditures through the outsourcing of production and trials, the quarterly change in earnings per share serves as an indicator of operational flexibility and the ability to generate value at low costs.
Direct competitors
BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Year-over-year earnings per share growth for the last twelve months CG Oncology, Inc. (CGON)|URGN: Year-over-year net earnings per share trend for the last twelve months|Bicara Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Personalis Inc PSNL|ERAS - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months DCTH (Delcath Corp)|Y-mAbs Therapeutics (YMAB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AURA (aurabiosciences.com)|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|Year-over-year earnings per share growth for the last twelve months ARAY|Quarterly EPS earnings growth SLS|ACTU - Earnings per share growth in annualized terms for the last twelve months|Citius Oncology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HURA|Protara Therapeutics, Inc. - Quarterly EPS earnings growth|FATE: Year-over-year earnings per share growth for the last twelve months|WHWK: Quarterly EPS earnings growth|TCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Champions Oncology Inc|Earnings per share growth in annualized terms for the last twelve months XBiotech USA XBIT|Year-over-year net earnings per share growth for the last 12 months CVM (CEL-SCI Corporation)|Year-over-year earnings per share growth rate for the last twelve months OSTX|Quarterly EPS earnings growth RADX (Radiopharm Theranostics)|Artiva Biotherapeutics Inc. (ARTV) - Earnings per share growth in annualized terms for the last twelve months|Adlai Nortye Limited - Quarterly EPS earnings growth|verupharma.com (VERU) - Year-over-year net earnings per share growth for the last 12 months|TPST: Quarterly EPS earnings growth|Xilio Therapeutics - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Renovaro Biosciences|Mural Bio - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Kairos Pharma Ltd (KAPA)|OKUR: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth GDTC (CytoMed Therapeutics Limited)|Curis Inc. - Year-over-year earnings per share growth for the last twelve months|APLM: Year-over-year net earnings per share growth for the last 12 months|Tharimmune Corporation - Year-over-year earnings per share growth rate for the last twelve months|ADVB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months genprex.com|CLDI (Calidi Biotherapeutics Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth sunshinebiopharma.com|Year-over-year earnings per share growth for the last twelve months Xenetic Biosciences (XBIO)|Salarius Pharma - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth AONC (American Oncology Network, Inc.)|BGNE - Year-over-year net earnings per share growth for the last 12 months|Checkpoint Therapeutics, Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Elevation Oncology Inc.|icadmed.com (ICAD) - Year-over-year earnings per share growth for the last twelve months|Ikena Oncology - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NTBL|VIRX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MOR|Year-over-year net earnings per share growth for the last 12 months NAYA Biosciences Inc NAYA|Ascentage Pharma Group Ltd - Year-over-year net earnings per share growth for the last 12 months
